• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CKM

CHALKOS METALS LIMITED

0.00% ! 0.0¢
Currently unlisted. Proposed listing date: 30 JUNE 2022 11:00 AM AEST ##
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CKM
Refund 		13/08/22 3 1.7K
13/08/22 Last post  nostradamus Comments Created with Sketch.  3  Views Created with Sketch.  1.7K 
CKM
Chalkos Metals CKM Discussions thread open 		04/08/22 29 14K
04/08/22 Last post  RichterSkale Comments Created with Sketch.  29  Views Created with Sketch.  14K 
CKM
Large Scale Alteration System 		01/07/22 12 4.5K
Metals & Mining SECTOR NEWS

Could this be the next U.S. Antimony Play?

Discover Utah Antimony right-arrow Created with Sketch.
RMX
16 Sep 2025
RED MOUNTAIN MINING LIMITED
01/07/22 Last post  tartanpenguin Comments Created with Sketch.  12  Views Created with Sketch.  4.5K 
CKM
IPO - Chalkos Metals Limited - 30 june 2022 11:00 AM AEST ## 		13/06/22 0 2.1K
13/06/22 Last post  IPO News Comments Created with Sketch.  0  Views Created with Sketch.  2.1K 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Amaero's big move: Exclusive deal, big targets, and a lot on the line

Amaero has just pulled off a deal that establishes its first-mover advantage: An exclusive five-year supply agreement with Titomic.
Tuesday's HotCopper trends: Race Oncology, Paladin Energy, and other daily winners | Sep 16 Race Oncology has been trending on the HotCopper forums after the biotech firm submitted an intellectual property patent application.
Future Battery Minerals identifies strong regolith gold anomalism at Canyon Future Battery MD and CEO, Nick Rathjen, joins HotCopper to unpack the company's glittering assay results at its Miriam project.
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
Market Close: Asian markets are visibly cautious, and gold profit-taking underscores that Good Afternoon and Welcome to HotCopper’s Market Close for Tuesday 16 September, I’m Jon Davidson. The index came back to life on Tuesday after Wall Street notched fresh records overnight, US futures just in the green once more in the final hour of trade. The next ...

Featured News

RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.